Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The previous link I posted doesn't work:
http://www.investopedia.com/articles/trading/06/level2quotes.asp
If you look at ECN order sizes for irregularities, you can tell when institutional players are trying to keep the buying quiet (which can mean a buyout or accumulation is taking place). We'll take a look at how you can detect similar irregularities below.
http://www.khq.com/story/34959158/biomaterials-market-to-reach-125152-billion-with-14-cagr-forecast-to-2020
Looks like Zimmer & Strykers are fighting for market share in ASIA:
http://www.idataresearch.com/zimmer-biomet-stryker-lead-billion-dollar-asia-pacific-hip-knee-implant-market-due-increase-viable-patient-population/
https://fintel.io/so/us/zbh
Blackrock added 16+ millions shares!
https://fintel.io/so/us/amda
Blackrock added 156,298 shares from 0 share before!
Market Makers (MM) - These are the players who provide liquidity in the marketplace. This means that they are required to buy when nobody else is buying and sell when nobody else is selling
Read more: Introduction To Level II Quotes http://www.investopedia.com/articles/trading/06/level2quotes.asp#ixzz4jKMbiSMU (read word by word)
MMs are working their magical moves on level 2 yesterday & this morning.
looks like a moderate sized seller just got out of the way, and all shares were absorbed at .2751 <<< this from ST...
suppose to read: short seller...could be the MMs thieves.
This is what I just found:
http://www.timesunion.com/allwcm/article/Albany-Molecular-bought-by-private-firms-for-922M-11199035.php
This is their 10K/A shows they went back & audited 3 yrs for Deferred tax asset:
http://ir.amriglobal.com/secfiling.cfm?filingID=1144204-17-25746&CIK=1065087
As you can see, in the process of being acquired...they have to go back 3 yrs to audit the book completely (long-lived assets, deferred tax asset, NOLs...all belong to "asset group")
http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf
(Page 50)
Their SEC filings:
http://ir.amriglobal.com/sec.cfm
I notice on ST...posters said bought shares, mark bullish (you notice jon...lmao), then turn around repeating Reverse Split...lol.
Think the movie "The Departed"...mole planting. Obviously, the feed isn't for people that following this amda day in & day out...most likely for the new board readers.
You remember DK posted a link to see the giant sale team in Brazil on the Sintex bus??? Possibly they are training the Zimmer sale team there:
http://www.biomet.com/regions/southAmerica/brazil.cfm?passedCategory=orthopedics
Zimmer's foot print in Brazil in not small.
I read that on ST just now. Very interesting. If amda has $300 mils debt with $8 mils cash, then I worry. But they have $8 mil cash with only $4 mil debt or even paid off the Hercules already (no default letter or 8K to update investors that they are asking for waiver from Hercules due to late to file the Financial Statements, both 10K & 10Q).
Today's short info shows inaccurate volume again...many days in a row for the past 2 weeks:
https://www.quandl.com/data/FINRA/FNSQ_AMDA-FINRA-NASDAQ-TRF-Short-Interest-AMDA
http://nakedshortreport.com/?index=AMDA
http://shortvolume.com/
even FIRNA:
http://regsho.finra.org/FNSQshvol20170606.txt
Today's volume should be: Vol / Avg. 346,011.00
https://www.google.com/finance?q=amda&ei=YEY3WZGhD8Kd2AbAy7aYDg
Also, please pay attention to the hidden narrative of the person's that bought this info. up. They always try to play dirty!
Think the movie "The Departed"...mole is planted in the conversation.
I have been watching all this time. I am thinking they are trying to play dirty again. Many shares available to shorts sometimes from margins accounts. They can't touch the shares in cash accounts. These hidden manipulators will try to take another assault if they see a chance. Everyday, at anytime til Jun 19, 2017. I am just expecting to see 8K...Hopefully, this time, Sonny give them a surprise uppercut!
Will see how many shares they shorted today when the info. get updated.
P.S. I think you should watch the movie "The Departed"...the mole was placed in the police force is mr. 7948.
Someone has to cover these 2.3mils shorted shares somewhow...hence the pps is at this range...wink to thieves!
IMO...The last thing i want is the CVR BO scenario like these:
http://www.investopedia.com/terms/c/cvr.asp
https://seekingalpha.com/article/4061451-innocoll-cvrs-potential-significant-gains-within-two-half-years
http://www.biospace.com/News/1-to-pay-cash-for-implex-corp-acquisition-108/15355220
I love the clean, quick, easy $ BO like this:
http://www.investors.com/news/tobira-shares-multiply-on-1-7-billion-buyout-from-allergan/
I believe deal is inked by zimmer pending the 8K to announce the news & the details...expecting a HALT soon...IMO!
I believe it's a dilutive acquisition for Zimmer....google dilutive acquision for more info.
NOT DILUTION ON AMDA!!!!! NOT!
https://fintel.io/so/us/amda
click on current shares column!
This is the theory of low pps... DO NOT SHAKE THE BUSH & ALARM THE SNAKES (smart investors out there)...dressing amda pps like a real POS...so they can accumulate more shares @ cheaper price.
MMs got orders from funds @ $X amount per share...the MMs will try their best to steal $$$ by manipulate the price per share to lower than $X amount per share, then DARKPOOL the shares to their customers (FUNDs) & of course will tuck in cheaper shares for themselves as well!
Is this the reason for the run up or some type of rulings that favor VHC..TIA..kinda late on the DDs on this.
The 2nd link i posted...it spells out very details of how to give a fair value of the target company...it says tons of info about "Deferred Tax Asset". That person that said 0 for NOLs on ST is BS again. It also says many important details about the future revenue that the intangible - IPs will generate!!! Also, the contracts too...etc...The BO price better be reasonable man. Like always..cafe, jon & his gangs spin BS all day long.
Some but not 100% due to tax code limitation. Still $$$ is $$$.
General Info about the $200+ Mils NOLs from amda:
http://www.pepperlaw.com/resource/2483/21d3
I am not a CPA...I believe the acquirer will have some, but not all benefits from amda's NOLs due to tax code limitation.
Zimmer has vast sale channels in place. Amedica's in-house production can't even handle the products to fulfill Zimmer's customers' orders. It will be a 3-some scenario as I am seeing. Kyocera will be mainly manufacture most of si3n4 products for Zimmer post acquistion.
All DDs have been done. As an investor, all I care is the Halt, BO 8K & how much per share. I am just waiting for the HALT...It could be any moment now.
Zimmer acquired LDR for $1 billion, but on their ER, it shows LDR only help to generate merely $100 mils in revenue...the valuation of amda better be reasonable!
This one I found last week which show a good example too...good case studies:
https://www.sec.gov/Archives/edgar/data/1123845/000112384501500005/fifth1-ksb.htm
What is going on with AMDA behind the scene is exactly in 2nd link! Measuring the Fair Value of AMDA for Purchase.
I bet you we will see a HALT real soon.
https://ocw.mit.edu/courses/sloan-school-of-management/15-514-financial-and-managerial-accounting-summer-2003/lecture-notes/lec7notes.pdf
http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf
Boston please read and comment on this.
IMO...I am speculating a HALT real soon!
Another company with Form NT filed for late 10K (on 3.16.2017) but also update investors about the waiver to lender:
https://seekingalpha.com/filing/3535091 (on 5.4.2017)
They all do have to ask for waiver and update investors except for AMDA...
Sonny, please give a pre-market news!
REF reading material for Consolidated financial statements:
https://www.becker.com/sites/default/files/uploaded/textbooks/2013_f-3_textbook_22-31.pdf
I believe Hercules knows something but due to confidential agreement. They can't disclose. There is no way that Form 10-K is way overdue they don't send out letter of default.
Amda also has to notify its investors as well if they ever receive such complaints from Hercules...
More & more solid evidence piles up...Sonny, give me a happy pre-market news!
Well, at least they have to tell us that they are default under Credit Agreement like these 8-Ks (non timely to provide Financials Statement).
The hercules' 1Q shows they make payment on time based on the outstanding loan amount by the end of 1Q.
Also, as I dig thru. these NT from these companies, I haven't even found 1 that has Form 8-K explains the same reason like AMDA...which telling us they are in the process of auditing their " long-lived assets"
Here I have another example of a company filed Form NT 10-Q on 5.11.2017:
https://seekingalpha.com/filing/3546476
It only takes 20 calendar days, they already filed Form 8-K to disclose the "b*tch*ng" from their lender due to non timely provide Financial Statements:
https://seekingalpha.com/filing/3578346
=========================================
AMDA:
Form NT 10-K filed on 3.31.2017 = 65 days so far.
Form NT 10-Q filed on 5.16.2017 = 20 days so far.
As we have discussed on ST, up to 3.31.2017, the hercules' loan has not been paid off yet (Hercules' 1Q still show outstanding loan amount):
http://investor.htgc.com/secfiling.cfm?filingID=1564590-17-8770 (Search Amedica)
The 2016 10-K is way overdue but still no "b*tch*ng" from lender Hercules. It seems very strange.
From April 1, 2017 til now, we are in dark regarding the outstanding of the loan.
Possibly the Hercules' loan has already been paid off during the 2Q hence no default letter send to them like the ones above?
On ST, you posted a different example as the lender does send out default letter aft they filed Form NT 10-Q, thus the company filed Form 8-K to disclose the info. to investors.
Looks like whoever posted that back in 2015 was employee/distributor?
So now it clearly tell us they are sleeping together for almost 2 yrs.
I have a feeling they will try to make another assault on the pps again.
Jun 19, 2017 or sooner ..about 10 more trading sessions.
Come on Sonny...give a a pre-market news.
Why don't you post the screen shot of zimmer forum about the BO rumor back in 2015..right at the same time they signed LOI?
FYI..they ganged up and got me banned again...lol
read my last post...now we know why no ER = full audit to produce GAAP = acquisition requirement!
GAAP is the keyword that triggered all on going audits:
https://media2.mofo.com/documents/1506practicepointersonfinancialstatement.pdf
zimmer trabecular metal (bone void filling like what amda's CSC) = toxic = tons of recalls on most of their products ...owning si3n4 from amda is golden move from zimmer:
1. zimmer acquired them for around $200 mils (stock + cash)
http://investor.zimmerbiomet.com/releaseDetail.cfm?ReleaseID=123310
2. tons of recalls:
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=133978
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=94419
there are many more out there, all over the internet!
buy amda = fix current lawsuit issues + future big money making in the ortho market!
http://files.shareholder.com/downloads/ZMH/4537764127x0x935394/34D8F3C6-70BA-42D5-AA4C-26E1620CC351/ZBH_2016_Annual_Report_Final_with_bookmarks_.pdf
Look into page 73 = $57+ millions active liability in lawsuits.
amda valuation = crazy...stock price + rev. = irrelevant!
Random time & day of the week, even on Sunday!
http://www.prnewswire.com/news-releases/bd-to-acquire-bard-for-24-billion-300443955.html
This is my OPINION:
This is my take...Sonny's vision is to bring CSC + recently obtained worldwide patent to patients which totally eliminate the needs of painful 2nd site bone graft from patients. Hip, Knee, Shoulder, Dental will come along later as titanium, peek, even ceramtec COC (ceramic on ceramic) has no match for amda's si3n4, even the 1st gen already beats these biomaterial out there.
Current, traditional methods:
https://www.spine-health.com/treatment/spinal-fusion/autograft-patients-own-bone
CSC method will be a game changer forever! Less complicated procedures for surgeons & less risk of getting lawsuits. Cheaper for insurance company. Greatly reduce the pain for patients (no need to harvest bone from 2nd site) & faster healing time. Most important is reducing the needs to inject invasive anti-infective drugs post surgeries (esp. peek biomaterial = very high infection rate post surgery).
2 years blind studies of SNAP (CSC+si3n4 compares to traditional method):
https://link.springer.com/article/10.1007%2Fs00586-017-5079-6
Peek material controls 80+% of spine surgery market. Ceramtec COC (Ceramic on Ceramic = noisy, risk of fracture or crack = re-operation risk = painful) controls 90%+ of hip replacement market. As we all know, JNJ, Strykers, Zimmer, etc metal on metal hip replacement is tainted with $ billions of liabilities in lawsuits. It's all over the internet & even on TV. The recent PRs shows Zimmer colab with amda successfully tested their hip replacment using zimmer's liner & si3n4 fermol head:
www.mdpi.com/2075-4442/4/4/35/pdf
Biocompatible properties:
www.ijmse.net/uploadfile/2016/0715/20160715041827481.pdf
This lead me to think that Zimmer & amda are actually sleeping together. Will Zimmer marry Amda..Guess we will find out very soon.
Amda's is actually stepping on 2 giant's toes! Whoever is buying Amda is actually hitting a jackpot. I believe K2M was trying to merge with them, but Sonny possibly rejected it. Sonny knew by heart that only giant like Zimmer or bigger (JNJ, Strykers, etc) will have enough resources to help to bring the benefits of CSC + si3n4 to unfortunate patients.
In addition, the orders from China giant Weigao pending CFDA approval alone is somewhat $200+ mils already. Also, their NOLs is also $200+ mils. Also, we are not even including the Japan market pending the PMA approval too.
To be honest, I really don't know how much amda really worths.
Now you can go thru. this checklist:
https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#57c8843d4bfc
zimmer just filed form SD to disclose the biomaterial they used in the yr. of 2016:
http://archive.fast-edgar.com//20170531/A322S22DZZ2RN2ZZ2HZM2MXOJRBFEZ22Z29G/
They are looking for bone void filling biomaterial, thus AMDA:
http://c.eqcdn.com/_5c7526ae538a6086a4025ef13f5136d2/amedica/db/224/1039/pdf/AMDA_Investor+Presentation_Jan++2017.pdf
Can you guys link the dots together?
Dana lyons:
https://www.linkedin.com/in/dana-lyons-a23b9550
was making millions @ zimmer, then switched to a 28 pennies stock...lmao..REALLY?
Recently obtained 2nd gen = king of biomaterial
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017027426
I will be pocketing more shares on Tuesday man. Something is really brewing behind the scene. The MMs are in control of the share price for now. Don't forget we might see clearing of modi CSC anytime, which later will predicate easily to original planned CSC & combine with 2nd gen Si3N4 = king!
What is your thought about my 3 examples of 8Ks filings from other companies with late SEC filings. It proves amda's 8K hinting an acquisition in process. It also proves doyour on ST was just spewing trash about all 8Ks filings (to explain the reason why filings was late) use the same language & phrase! Obviously, it's NOT.
This auditing ebook I pasted yesterday:
https://books.google.com/books?id=zzdBBAAAQBAJ&pg=PA596&lpg=PA596&dq=long-lived+assets+auditing&source=bl&ots=qTGXGo7OtD&sig=eXnQyaXjYgDquiSFS18RINqrq0s&hl=en&sa=X&ved=0ahUKEwiouK_qnY7UAhXGilQKHSzEAes4ChDoAQgwMAM#v=snippet&q=long-lived%20asset&f=false
As i read through it, it's a 2 parties (target & acquirer) auditing process for acquisition (page 599).
Alright folks, this is one more example of LATE FILINGS without the phrase of "long-lived assets" auditing in their 8Ks:
On 3.20.2017, they filed form NT 10-K for non timely to file their 10K:
http://ir.jambajuice.com/phoenix.zhtml?c=192409&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNDgwMDY5JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
On 3.24.2017, they filed form 8-K to explain why it was late, the language inside the 8K has no such phrase "long lived-assets" like amda's 8K:
http://ir.jambajuice.com/phoenix.zhtml?c=192409&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNDg5ODg2JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
On 5.15.2017, they filed from NT 10-Q for non timely to file their 10Q:
http://ir.jambajuice.com/phoenix.zhtml?c=192409&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNTk5MTgwJkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
On 5.19.2017, they file form 8-K to explain why it was late, the language inside the 8K has no such phrase "long lived-assets" like amda's 8K:
http://ir.jambajuice.com/phoenix.zhtml?c=192409&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjA5NDc0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
As you can see, this is 3rd example so far that proves amda's 8K from yesterday really hinting the on-going audits in process is related to acquisition!
As I said earlier, other companies that have LATE SEC filings on 10K or 10Q, they DON'T use the same language or phrase of "long-lived asset" auditing in their 8-K. Below is the example of JRJR just exactly like the previous example of IMNP:
On 11.15.2016, they filed Form NT 10-Q (non timely to file 10Q)
http://www.jrjrnetworks.com/profiles/investor/secDL.asp?b=2203&c=1403085&ID=000162828016021501/0001628280-16-021501
On 11.29.2016, they filed the 8-K (like the ones amda filed today) explaining the reasons why it was late. In the filing below, can't find the phrase "long-lived asset" auditing like we saw in amda's 8K:
http://www.jrjrnetworks.com/profiles/investor/secDL.asp?b=2203&c=1403085&ID=000162828016021711/0001628280-16-021711
On 3.31.2017, they filed Form NT 10-K (non timely to file 10K)
http://www.jrjrnetworks.com/profiles/investor/secDL.asp?b=2203&c=1403085&ID=000162828017003248/0001628280-17-003248
On 4.20.2017, they filed the 8-K (like the ones amda filed today) explaining the reasons why it was late. I can't find the phrase "long-lived asset" audting as well! Here is the 8K they filed:
http://www.jrjrnetworks.com/profiles/investor/secDL.asp?b=2203&c=1403085&ID=000162828017003963/0001628280-17-003963
I apologize for so many different posts. Here this is another one pointing to acquisition focusing on AS360 (evaluate the value of long-lived assets) and acquisition:
https://books.google.com/books?id=0NxNDQAAQBAJ&pg=PA74&lpg=PA74&dq=asc+360+and+acquisition&source=bl&ots=c1XAOUsT5p&sig=DREGoW4VpDY8ug8nAGO-dnMR69c&hl=en&sa=X&ved=0ahUKEwjI0eWRqI_UAhVK8IMKHSbVBJo4ChDoAQg3MAM#v=onepage&q=asc%20360%20and%20acquisition&f=false
More interesting link about asset transfer(it's more like from the perspective of the buyer):
http://accounting-financial-tax.com/2009/09/long-lived-assets-disposed-of-by-sale/
You guys see it's all the same!!!
Dispose of sale of assets:
Under U.S. GAAP, testing a long-lived asset (asset group) for impairment is a two-step process:
Step 1 — The entity tests the long-lived asset or asset group for recoverability by comparing the carrying amount of the long-lived asset or asset group with the sum of the undiscounted future cash flows and the eventual disposal of the asset.[color=red][/color] If the carrying amount of the long-lived asset or asset group is determined to be greater than the sum of the undiscounted future cash flows, the entity would need to perform step 2. Step 2 — If the long-lived asset or asset group fails the recoverability test in step 1, the entity must record an impairment expense for the difference between the carrying amount and the fair value of the long-lived asset or asset group.
https://www.iasplus.com/en-us/standards/ifrs-usgaap/impairment-of-assets
This is the language in their 8-k today:
Prior to filing the Form 10-Q the Company requires additional time to fully consider whether there is any potential impairment in relation to certain of its long-lived assets in connection with the completion of the audit of its 2016 financial results and the filing of its 2016 Annual Report on Form 10-K.
Please do not tell me it's about selling a nut, a bolt, a chair and a table!